Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
XenTech Logo
XenTech Growth Score
83
CB Rank
599301
Heat Score
27
XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification.
Founded
obfuscation
PrivateSeed Évry, Ile-de-France, France11-50 www.xentech.eu/
Biotechnology
Health Care
Life Science
Overview

XenTech
Total Funding
obfuscation
Growth Score
83
Heat Score
27

Total Funding
obfuscation
obfuscation
Seed raised
obfuscation
Growth Score83
-3 pts
in past quarter
Heat Score 27
0 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About XenTech

CB Rank
599301
XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification.
Founded
obfuscation
PrivateSeed Évry, Ile-de-France, France11-50 www.xentech.eu/
Biotechnology
Health Care
Life Science

Funding Rounds

Seed
OBF
in
obfuscation
Non-equity Assistance
OBF
in
obfuscation

Key People

Details

Operating Status Active
Company Type For Profit
Founders  Pascal Leuraud, Saraban Tahura
About the Company
XenTech is an innovative biotech/CRO company specialized in the preclinical cancer drug efficacy evaluation and the identification of biomarkers and therapeutic targets. They offer a unique collection of patient-derived tumor xenografts
Phone Number +33 (0)1 60 87 89 80
Predictions & Insights

Growth Prediction

See this Growth Prediction

Products & Services

Patient-Derived Xenograft (PDX) Models
Human tumor samples grafted into immunodeficient mice to create stable, transplantable cancer models for preclinical drug efficacy testing and biomarker discovery.
MATCH-R PDX Collection
A specialized panel of PDX models derived from patients with acquired resistance to recent cancer therapies, used to study drug resistance mechanisms and test new treatments.

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed
obfuscation
Seed Round - XenTech Logo
Seed Round - XenTech
1
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
Aurinvest Logo
Aurinvest
—
Seed Round - XenTech Logo
Seed Round - XenTech
—
Aurinvest Logo
Aurinvest
—
Seed Round - XenTech Logo
Seed Round - XenTech
—
Aurinvest Logo
Aurinvest
—
Seed Round - XenTech Logo
Seed Round - XenTech
—
Aurinvest Logo
Aurinvest
—
Seed Round - XenTech Logo
Seed Round - XenTech
—
Aurinvest Logo
Aurinvest
—
Seed Round - XenTech Logo
Seed Round - XenTech
—
Market Intelligence
People
View Profiles & Contacts
Headcount 11-50 Employee Profiles 5 Contacts 4

Employee Profiles

News
Technology
View Tech Report

Monthly Web Visits

951
69.22%
 in past month

IT Spend

$444.9KThis year, XenTech is projected to spend $444.9K on IT, according to Aberdeen.

Active Website Tech Count

1XenTech is actively using the technology Viewport Meta for its website, according to BuiltWith.

Total IP

4The intellectual property of XenTech includes 2 registered patents primarily in the 'Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation Or Genetic Engineering' category, according to IPqwery. Additionally, XenTech has registered 2 trademarks with the most popular class being 'Pharmaceutical, veterinary and sanitary products', according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is XenTech's headquarters? XenTech is located in Évry, Ile-de-France, France.Who invested in XenTech? XenTech has 2 investors including Aurinvest and  IncubAlliance Paris-Saclay.When was the last funding round for XenTech? XenTech closed its last funding round on
obfuscation
from a Seed round.Who are XenTech's competitors? Alternatives and possible competitors to XenTech may include The Jackson Laboratory, LabCorp, and  Charles River Laboratories International.How much funding has XenTech raised to date? XenTech has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|